Coya Therapeutics, Inc. (COYA) vs LENZ Therapeutics, Inc. (LENZ)
Coya Therapeutics, Inc. and LENZ Therapeutics, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and LENZ Therapeutics, Inc. are of similar size ($121.5M and $117.4M). Coya Therapeutics, Inc. has the higher net margin (−270.2% vs −586.7%) and the lower return on invested capital (−15,230.9% vs 0.00%). Across the 15 metrics below, Coya Therapeutics, Inc. leads on 8 and LENZ Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | COYA | LENZ | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.69% | 65.16% |
| Operating margin | (288.70%) | (631.70%) | 0.00% |
| Net margin | (270.22%) | (586.74%) | 0.00% |
| Free cash flow margin | (221.64%) | (532.80%) | 0.00% |
| Return on equity | (60.54%) | (59.21%) | (57.72%) |
| Return on assets | (53.66%) | (55.52%) | (49.22%) |
| Return on invested capital | (15,230.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack